A senior executive at Eli Lilly and Co. whose mission was to transform the Indianapolis drug maker into an "oncology powerhouse" is leaving after less than two years on the job.
Topstories, Indianapolis Star
Wed, 01/26/2011 - 3:56am
A senior executive at Eli Lilly and Co. whose mission was to transform the Indianapolis drug maker into an "oncology powerhouse" is leaving after less than two years on the job.